Tylenol Shortages in U.S.

TUESDAY, April 7, 2020 (HealthDay News) -- Tylenol is becoming hard to find at some U.S. pharmacies because people are scooping it up in the belief that it can help fight COVID-19, even though there's no firm evidence.

"We are experiencing record high demand for Tylenol, and despite our producing and shipping product at historic highs, we are experiencing a temporary shortage in some regions in the U.S.," said Kim Montagnino, Global Corporate Media Relations Senior Director, Johnson & Johnson, the makers of Tylenol, CBS News reported.

"We are committed to maintaining our increased production, including running lines up to 24/7 to maximize supply," Montagnino added.

The company is also encouraging stores to limit how much Tylenol people can buy, CBS News reported.

Despite the demand for Tylenol, some medical experts say there's no proof that Tylenol or acetaminophen (Tylenol's main ingredient) is better or safer than ibuprofen for people with COVID-19.

"It's just not true. It is OK to take Tylenol, it is OK to take ibuprofen. There is no association with severity in symptoms or outcome to the virus," Dr. David Agus said on "CBS This Morning" last month.

Copyright © 2019 HealthDay. All rights reserved.


What is the Wuhan coronavirus? See Answer

Health Solutions From Our Sponsors